- Scott was the 9th patient in the UK to participate in a CAR T-cell therapy trial, following a relapse from Acute lymphoblastic leukaemia (ALL). Scott shares with us how this…
Reducing the risk of infection from cosmetic products and toiletries after your stem cell transplant
In this blog, our Science Communications Manager, Jonathan Kay, looks at how make-up products could cause infections post-transplant and the steps you can take to help reduce the…- Anthony Nolan is proud to facilitate three stem cell transplants a day. Though they give patients a vital second chance of life, they can also lead to severe post-transplant…
- Against daily news articles on COVID-19’s impact and possible new treatments or vaccines, it can be very hard to get a clear…
- In this blog, our Science Communications Manager, Jonathan Kay, looks at a recent study that highlights the potential benefits of selecting a cord blood transplant over a matched…
- Umbilical cord blood (UCB) has huge potential, not only as a successful alternative source of hematopoietic blood cells for transplant/clinical application, but in research and…
- Ensuring care has the patient at the centre is a key aim for the NHS and something we’re particularly interested in at Anthony Nolan. Our post-transplant care pathway sets out one…
- Here, Anthony Nolan’s Chief Executive, Henny Braund, gives an overview of current and emerging treatments for blood cancer and the developments needed to give patients the best…
- Through the Anthony Nolan Cell & Gene Therapy Service’s provision of cellular material to cell and gene therapy researchers, we are familiar with industry standards and…
- Our impact Our research has significantly influenced the world of stem cell transplantation, and continues to contribute to major improvements in clinical outcomes –…
This page has been auto translated by Google Translate. Confirm any health information with your own medical team before acting upon it. All printed materials and PDFs are available in English only.